Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Boomskidon Jan 23, 2023 11:53pm
95 Views
Post# 35241474

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:This is why i love this board

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:This is why i love this board I was never sure that I would make a lot of money on Bioasis. I was confident that if xB3 worked as hoped that it would be worth a lot of money. It was also clear that I was worried about Bioasis management as early as 2012, and I posted those worries.

I was worried that Bioasis would not prove the value of xB3. They chose not to do that, astonishingly, and I was right to worry about it. I and most others had diminishing concerns that xB3 would fail. All studies that we know of have increased everybody's confidence in xB3. It's a sad thing that management never kept up with the technology.

Are you able to understand the nuance there, Craig? Bioasis could be no more valuable than the effectiveness of both mangement and the technology. We need both. So far? xB3, 98.6, management, 0.

jd
<< Previous
Bullboard Posts
Next >>